Verzenios

Verzenios (abemaciclib) is an oral prescription medication used to treat certain types of breast cancer. It belongs to a class of drugs known as CDK4/6 inhibitors. This medication works by slowing or stopping the growth of cancer cells. Always consult a healthcare provider for personalized guidance.

Verzenios (abemaciclib) is prescribed to treat advanced or metastatic breast cancer in adults. It is often used in combination with hormone therapy (e.g., fulvestrant or aromatase inhibitors) for hormone receptor-positive, HER2-negative breast cancer. This medication may also be used as monotherapy when prior endocrine therapy has not been effective.

Verzenios (abemaciclib) works by inhibiting specific enzymes in cancer cells, which helps slow their growth. Patients may experience improved symptoms related to their condition over time. Common effects include changes in blood cell counts, which are monitored regularly by healthcare providers.

Verzenios (abemaciclib) should be taken exactly as prescribed by a healthcare professional. It is important to attend all scheduled medical appointments for monitoring, including blood tests. Patients should report any unusual symptoms, such as fever, chills, or persistent fatigue, to their doctor immediately.

Verzenios (abemaciclib) may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Grapefruit and grapefruit juice may also interact with this medication. Patients should inform their healthcare provider about all prescription, over-the-counter, and herbal products they are using.